Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes.

Clin Immunol Commun · 2025 · PMC13056382 · PMID 41953699

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Patients with longer time to IgG + memory B cell reconstitution, did tend to have longer hypogammaglobulinemia after RTX, but this did not reach statistical significance (HR=0.83, 95 %CI=[0.66–1.03], p = 0.08). 3.6.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.